Cardioprotective effects of enteral vs. parenteral lactoferrin administration on myocardial ischemia-reperfusion injury in a rat model of stunned myocardium.

MLA

Omiya, Keisuke, et al. “Cardioprotective Effects of Enteral vs. Parenteral Lactoferrin Administration on Myocardial Ischemia-Reperfusion Injury in a Rat Model of Stunned Myocardium.” BMC Pharmacology & Toxicology, vol. 23, no. 1, Oct. 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s40360-022-00619-w.

APA

Omiya, K., Nakadate, Y., Oguchi, T., Sato, T., Matsuoka, T., Abe, M., Kawakami, A., Matsukawa, T., & Sato, H. (2022). Cardioprotective effects of enteral vs. parenteral lactoferrin administration on myocardial ischemia-reperfusion injury in a rat model of stunned myocardium. BMC Pharmacology & Toxicology, 23(1), 1–10. https://doi.org/10.1186/s40360-022-00619-w

Chicago

Omiya, Keisuke, Yosuke Nakadate, Takeshi Oguchi, Tamaki Sato, Toru Matsuoka, Masako Abe, Akiko Kawakami, Takashi Matsukawa, and Hiroaki Sato. 2022. “Cardioprotective Effects of Enteral vs. Parenteral Lactoferrin Administration on Myocardial Ischemia-Reperfusion Injury in a Rat Model of Stunned Myocardium.” BMC Pharmacology & Toxicology 23 (1): 1–10. doi:10.1186/s40360-022-00619-w.